Literature DB >> 30968748

Phenotypic Variation Between Stromal Cells Differentially Impacts Engineered Cardiac Tissue Function.

Tracy A Hookway1, Oriane B Matthys1,2, Federico N Mendoza-Camacho1, Sarah Rains1,3, Jessica E Sepulveda1,4, David A Joy1,2, Todd C McDevitt1,5.   

Abstract

IMPACT STATEMENT: Understanding the relationship between parenchymal and supporting cell populations is paramount to recapitulate the multicellular complexity of native tissues. Incorporation of stromal cells is widely recognized to be necessary for the stable formation of stem cell-derived cardiac tissues; yet, the types of stromal cells used have varied widely. This study systematically characterized several stromal populations and found that stromal phenotype and morphology was highly variable depending on cell source and exerted differential impacts on cardiac tissue function and induced pluripotent stem cell-cardiomyocyte phenotype. Therefore, the choice of supporting stromal population can differentially impact the phenotypic or functional performance of engineered cardiac tissues.

Keywords:  cardiac microtissues; cardiomyocytes; fibroblasts; heterotypic interactions; stem cell-derived tissues; stromal cells

Mesh:

Year:  2019        PMID: 30968748      PMCID: PMC6535958          DOI: 10.1089/ten.TEA.2018.0362

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  69 in total

1.  Tissue engineering of vascularized cardiac muscle from human embryonic stem cells.

Authors:  Oren Caspi; Ayelet Lesman; Yaara Basevitch; Amira Gepstein; Gil Arbel; Irit Huber Manhal Habib; Lior Gepstein; Shulamit Levenberg
Journal:  Circ Res       Date:  2007-01-11       Impact factor: 17.367

2.  Cardiac fibroblasts are major production and target cells of adrenomedullin in the heart in vitro.

Authors:  Y Tomoda; K Kikumoto; Y Isumi; T Katafuchi; A Tanaka; K Kangawa; K Dohi; N Minamino
Journal:  Cardiovasc Res       Date:  2001-03       Impact factor: 10.787

3.  Effect of Glucose on 3D Cardiac Microtissues Derived from Human Induced Pluripotent Stem Cells.

Authors:  Michael Balistreri; Justin A Davis; Katherine F Campbell; André Monteiro Da Rocha; Marjorie C Treadwell; Todd J Herron
Journal:  Pediatr Cardiol       Date:  2017-07-27       Impact factor: 1.655

4.  Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.

Authors:  Nathan Cho; Shadi E Razipour; Megan L McCain
Journal:  Exp Biol Med (Maywood)       Date:  2018-03-04

5.  Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair.

Authors:  Milena B Furtado; Mauro W Costa; Edward A Pranoto; Ekaterina Salimova; Alexander R Pinto; Nicholas T Lam; Anthony Park; Paige Snider; Anjana Chandran; Richard P Harvey; Richard Boyd; Simon J Conway; James Pearson; David M Kaye; Nadia A Rosenthal
Journal:  Circ Res       Date:  2014-03-20       Impact factor: 17.367

6.  Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro.

Authors:  George Kensah; Angelica Roa Lara; Julia Dahlmann; Robert Zweigerdt; Kristin Schwanke; Jan Hegermann; David Skvorc; Anke Gawol; Azadeh Azizian; Stefan Wagner; Lars S Maier; Andreas Krause; Gerald Dräger; Matthias Ochs; Axel Haverich; Ina Gruh; Ulrich Martin
Journal:  Eur Heart J       Date:  2012-10-26       Impact factor: 29.983

7.  Derivation of multipotent mesenchymal precursors from human embryonic stem cells.

Authors:  Tiziano Barberi; Lucy M Willis; Nicholas D Socci; Lorenz Studer
Journal:  PLoS Med       Date:  2005-06-28       Impact factor: 11.069

8.  Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy.

Authors:  Claudia Bang; Sandor Batkai; Seema Dangwal; Shashi Kumar Gupta; Ariana Foinquinos; Angelika Holzmann; Annette Just; Janet Remke; Karina Zimmer; Andre Zeug; Evgeni Ponimaskin; Andreas Schmiedl; Xiaoke Yin; Manuel Mayr; Rashi Halder; Andre Fischer; Stefan Engelhardt; Yuanyuan Wei; Andreas Schober; Jan Fiedler; Thomas Thum
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

9.  Miniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses.

Authors:  Nathaniel Huebsch; Peter Loskill; Nikhil Deveshwar; C Ian Spencer; Luke M Judge; Mohammad A Mandegar; Cade B Fox; Tamer M A Mohamed; Zhen Ma; Anurag Mathur; Alice M Sheehan; Annie Truong; Mike Saxton; Jennie Yoo; Deepak Srivastava; Tejal A Desai; Po-Lin So; Kevin E Healy; Bruce R Conklin
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

10.  Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues.

Authors:  Stephanie M Ravenscroft; Amy Pointon; Awel W Williams; Michael J Cross; James E Sidaway
Journal:  Toxicol Sci       Date:  2016-04-28       Impact factor: 4.849

View more
  8 in total

Review 1.  Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine.

Authors:  Martha E Floy; Taylor D Mateyka; Koji L Foreman; Sean P Palecek
Journal:  Stem Cell Res       Date:  2020-04-27       Impact factor: 2.020

2.  A combined human gastruloid model of cardiogenesis and neurogenesis.

Authors:  Zachary T Olmsted; Janet L Paluh
Journal:  iScience       Date:  2022-05-30

3.  Modeling Human TBX5 Haploinsufficiency Predicts Regulatory Networks for Congenital Heart Disease.

Authors:  Irfan S Kathiriya; Kavitha S Rao; Giovanni Iacono; W Patrick Devine; Andrew P Blair; Swetansu K Hota; Michael H Lai; Bayardo I Garay; Reuben Thomas; Henry Z Gong; Lauren K Wasson; Piyush Goyal; Tatyana Sukonnik; Kevin M Hu; Gunes A Akgun; Laure D Bernard; Brynn N Akerberg; Fei Gu; Kai Li; Matthew L Speir; Maximilian Haeussler; William T Pu; Joshua M Stuart; Christine E Seidman; J G Seidman; Holger Heyn; Benoit G Bruneau
Journal:  Dev Cell       Date:  2020-12-14       Impact factor: 12.270

Review 4.  Recent Advances in Single-Cell Profiling and Multispecific Therapeutics: Paving the Way for a New Era of Precision Medicine Targeting Cardiac Fibroblasts.

Authors:  Brandon Ason; Milena B Furtado; Sally Yu Shi; Xin Luo; Tracy M Yamawaki; Chi-Ming Li
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

5.  Engineering spatial-organized cardiac organoids for developmental toxicity testing.

Authors:  Plansky Hoang; Andrew Kowalczewski; Shiyang Sun; Tackla S Winston; Adriana M Archilla; Stephanie M Lemus; A Gulhan Ercan-Sencicek; Abha R Gupta; Wenzhong Liu; Maria I Kontaridis; Jeffrey D Amack; Zhen Ma
Journal:  Stem Cell Reports       Date:  2021-04-22       Impact factor: 7.765

6.  Developmental lineage of human pluripotent stem cell-derived cardiac fibroblasts affects their functional phenotype.

Authors:  Martha E Floy; Sophie E Givens; Oriane B Matthys; Taylor D Mateyka; Charles M Kerr; Alexandra B Steinberg; Ana C Silva; Jianhua Zhang; Ying Mei; Brenda M Ogle; Todd C McDevitt; Timothy J Kamp; Sean P Palecek
Journal:  FASEB J       Date:  2021-09       Impact factor: 5.834

Review 7.  Extracellular Vesicles in Cardiac Regeneration: Potential Applications for Tissues-on-a-Chip.

Authors:  Karl T Wagner; Trevor R Nash; Bohao Liu; Gordana Vunjak-Novakovic; Milica Radisic
Journal:  Trends Biotechnol       Date:  2020-09-19       Impact factor: 21.942

Review 8.  Stem cell-based vascularization of microphysiological systems.

Authors:  Shane Browne; Elisabeth L Gill; Paula Schultheiss; Ishan Goswami; Kevin E Healy
Journal:  Stem Cell Reports       Date:  2021-04-08       Impact factor: 7.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.